| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8964281 | SEMERGEN - Medicina de Familia | 2018 | 9 Pages |
Abstract
The current knowledge about biosimilars among PC physicians is low. The critical areas in need of further training include specific information on biosimilars currently available in PC setting, as well as key aspects regarding prescription, interchangeability and pharmacovigilance requirements. Six out of ten doctors do not know of any biosimilar used in PC in Spain.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
R.M. Micó-Pérez, C. Payares-Herrera, P.I. Palomo-Jiménez, J. Sánchez-Fierro, C. Avendaño-Solá, J.L. Llisterri-Caro,